Heparan sulfate (HS) proteoglycans (HSPGs) bind to multiple growth factors/morphogens and regulate their signaling. 6-O-sulfation (6S) of glucosamine within HS chains is critical for many of these ligand interactions. Sulf-1 and Sulf-2, which are extracellular neutral-pH sulfatases, provide a novel post-synthetic mechanism for regulation of HSPG function by removing 6S from intact HS chains. The Sulfs can thereby modulate several signaling pathways, including the promotion of Wnt signaling. We found induction of SULF2 transcripts and Sulf-2 protein in human lung adenocarcinoma and squamous cell carcinoma, the two major classes of nonsmall-cell lung carcinomas (NSCLCs). We confirmed widespread Sulf-2 protein expression in tumor cells of 10/10 surgical specimens of human lung squamous carcinomas. We studied five Sulf-2 þ NSCLC cell lines, including two, which were derived by cigarette-smoke transformation of bronchial epithelial cells. shRNAmediated Sulf-2 knockdown in these lines caused an increase in 6S on their cell surface and in parallel reversed their transformed phenotype in vitro, eliminated autocrine Wnt signaling and strongly blunted xenograft tumor formation in nude mice. Conversely, forced Sulf-2 expression in non-malignant bronchial epithelial cells produced a partially transformed phenotype. Our findings support an essential role for Sulf-2 in lung cancer, the leading cancer killer.
Introduction
Lung cancer is the leading cause of cancer deaths worldwide, with the majority of cases resulting from exposure of the airways to tobacco-smoke carcinogens (Sato et al., 2007) . Further understanding of the molecular basis of lung cancer is needed, since current treatment options are frequently inadequate (Osada and Takahashi, 2002; Sato et al., 2007) . Although heparan sulfate (HS) proteoglycans (HSPGs) are ubiquitous elements of the cell surface/extracellular matrix and perform critical signaling functions in development and normal physiology (Bernfield et al., 1999; Habuchi et al., 2004; Bishop et al., 2007) , they have received scant attention in lung cancer. HSPGs consist of HS chains containing repeating uronic acid and glucosamine disaccharide units, with the chains covalently linked to a restricted set of core proteins. The functions of HSPGs are mediated through their binding to a myriad number of ligands, including growth factors and morphogens. The pattern of four sulfation modifications on the sugars largely dictates binding specificity (Esko and Lindahl, 2001; Gallagher, 2001) . The 6-O-sulfation (6S) of glucosamine is known to be critical in the binding of many protein ligands (Gallagher, 2001; Habuchi et al., 2004) . One mechanism of spatiotemporal regulation of 6S in the embryo and adults is through expression of HS 6-O-sulfotransferases, which add sulfate esters to nascent HS chains (Brickman et al., 1998; Habuchi et al., 2004 Habuchi et al., , 2007 .
A novel post-synthetic mechanism of regulating 6S on HSPGs emerged several years ago with the cloning and characterization of two novel extracellular sulfatases (Sulf-1 and Sulf-2) in human (Morimoto-Tomita et al., 2002) , following the original identification of Sulf-1 in quail embryo (Dhoot et al., 2001) . These neutral-pH endosulfatases remove 6S in highly sulfated subdomains of intact heparin/HSPGs (Ai et al., 2003; Viviano et al., 2004; Morimoto-Tomita et al., 2005; Lamanna et al., 2008) . Desulfation of HSPGs/heparin by the Sulfs reduces interactions with protein ligands, including Wnts, FGFs and GDNF (Ai et al., 2003 Uchimura et al., 2006) , and modulates their signaling. The importance of these enzymes in development is established by the abnormal phenotypes observed in single and double sulf knockouts in mice (Lum et al., 2006; Ai et al., 2007; Holst et al., 2007; Ratzka et al., 2008) . Consistent with many precedents for oncodevelopmental genes, Sulf-2 has been suggested to be relevant in several cancers (Morimoto-Tomita et al., 2005; Nawroth et al., 2007; Lai et al., 2008) . Here, we present evidence that Sulf-2 promotes human lung carcinogenesis.
Results
Sulfs are expressed in lung tumors and lung cancer cell lines Initially, we looked for dysregulated expression of SULF genes in human lung cancer by mining public microarray data. Relative to normal lung, SULF1 expression was increased by three-to six-fold in both adenocarcinoma (P ¼ 0.006) and squamous cell carcinoma (P ¼ 0.004) ( Supplementary Figure 1a) , the two major classes of non-small-cell lung carcinoma (NSCLC) . Data from the Consortium for Functional Glycomics (http://www.functionalglycomics.org/glyco mics/publicdata/microarray.jsp) provided information on both SULFs in lung cancer (Figure 1a ). Paired samples of lung squamous carcinoma and non-malignant neighboring tissue were obtained from 10 patients undergoing surgical resection. SULF1 expression increased in 10/10 pairs with a mean increase of 18 ± 2.4-fold (P ¼ 0.0005). SULF2 expression increased in 8/ 10 pairs, with a mean increase of 3 ± 0.3-fold (P ¼ 0.003). Quantitative PCR analysis of SULF1 and SULF2 in archived cases of lung carcinoma verified these findings (Figures 1b and c) . (SULF1 and SULF2 levels increased 12 ± 1.5-fold (P ¼ 0.008) and 4 ± 0.3-fold (P ¼ 0.05), respectively in squamous carcinomas, and 3 ± 0.4-fold for both (P ¼ 0.003 and P ¼ 0.002, respectively) in adenocarcinomas).
We next determined SULF expression in a series of NSCLC cell lines, all of which form tumors in immunocompromised mice ( Supplementary Table 1 ). In addition, we evaluated two novel cell lines, B-ST and P-ST, which were obtained by exposing BEAS2B cells (a non-malignant human bronchial epithelial cell line, denoted 'B-C' for 'BEAS2B control') and primary human bronchial epithelial cells (denoted 'P-C' for 'primary control') to an aqueous extract of cigarette smoke for several days (Lemjabbar-Alaoui et al., 2006) . B-ST and P-ST ('ST' denotes 'smoke-transformed') are immortalized, exhibit a transformed phenotype in culture and form tumors when injected into nude mice (Lemjabbar-Alaoui et al., 2006) as NSCLC lines. Strong expression of SULF2 in B-ST and P-ST cells, whereas minimal levels of SULF2 in the parental cells (B-C and P-C) was found by reverse transcription-PCR ( Figure 1d ) and quantitative PCR ( Supplementary Figure 1b ). In addition, 3/16 of the conventional NSCLC cell lines were positive for SULF1 and 5/16 were positive for SULF2. No line showed simultaneous expression of both SULFs. Among the SULF þ cell lines, four could be classified as squamous cell carcinomas, five as adenocarcinomas and one as a large-cell carcinoma ( Supplementary Table 1 ). There was no statistically significant correlation between SULF expression and whether or not the cell lines harbored oncogenic mutations in KRAS or EGFR (Supplementary Table 1 ). We concentrated on Sulf-2 for mechanistic studies because of its more frequent expression in the lines (7/18). We confirmed that all seven SULF2 þ lines (including B-ST and P-ST) were strongly positive for Sulf-2 protein in both conditioned media (75 kDa) and in detergent lysates (125 kDa) ( Figure 1e ). The 125-and 75-kDa components correspond, respectively, to the unprocessed pro-protein and the amino-terminal subunit of Sulf-2 (Morimoto-Tomita et al., 2002; Tang and Rosen, 2009 ). B-C and P-C cells showed no detectable signal. Thus, smoke-induced transformation is accompanied by a dramatic induction of Sulf-2.
We performed immunocytochemistry for Sulf-2 in NSCLC tumors (10 cases each of squamous cell carcinoma and adenocarcinoma) selected from archived surgical specimens (Supplementary Table 2 ). Normal lung tissue from the same specimens served as controls. Paraffin sections were stained with a newly developed Sulf-2 monoclonal antibody ( Supplementary Figure 3 ). All 10 cases of squamous cell carcinoma showed some degree of staining for Sulf-2 in the tumor cells. The staining was patchy and accentuated in the cells at the periphery of nests ( Figure 2 ). The percentage of positive cells was variable and the intensity of staining ranged from faint to intense ( Supplementary Table 2 ). No correlation was found between stage of tumor differentiation and percentage of positive cells or intensity of staining. In striking contrast, there was no staining of adenocarcinoma cells in any of the cases. This was surprising since three of the NSCLC cell lines with SULF2 expression (Calu-3, Calu-6 and A549) could be classified as adenocarcinomas ( Supplementary Table 1 ). However, both adenocarcinomas and squamous cell carcinomas showed conspicuous staining of tumor stroma, including spindle-shaped cells and endothelial cells of blood vessels. In control tissue distant from the tumors, endothelial cell staining was also seen ( Figure 2b ), but normal airway epithelium, except for rare basal cells, was negative for Sulf-2.
Knockdown of Sulf-2 or expression of dominant-negative Sulf-2 reduces growth of lung cancer cells
We used a previously developed lentiviral short-hairpin RNA (shRNA) strategy (Nawroth et al., 2007) to achieve knockdown of Sulf-2 in NSCLC lines. We transduced five of the Sulf-2 þ lines (H460, H292, Calu-6, P-ST and B-ST cells) with either a specific shRNA (PLV-1413 or PLV-1143) (Nawroth et al., 2007) or a control shRNA (PLV-Ctrl) containing an irrelevant sequence. Sulf-2 protein expression was strongly reduced (>90%) in all of the lines after transduction with PLV-1413 or PLV-1143, as compared with the control cells ( Figure 3a ). To determine the effects of Sulf-2 knockdown on the sulfation status of HSPGs, we used a phage-display antibody (RB4CD12) whose binding to HSPGs depends on 6S (Dennissen et al., 2002; Hossain et al., 2009 ). Transduction of Sulf-2 þ lines with PLV-1413 increased the level of the RB4CD12 epitope on the cell surface relative to that of control-treated cells by 30 to 37% (Figure 3b ). The same treatment had no effect on the epitope in a Sulf-2 À line (H1975).
Whereas no difference in growth was observed between the PLV-Ctrl-transduced cells and parental cells, both SULF2-specific shRNAs induced a marked reduction in the five Sulf-2 þ lines (46-50% reduction) ( Figure 3c ). PLV-1413 transduction had no effect on H1975 cells as compared with the controls. Mutation of two cysteines in the catalytic domain of HSulf-2 (S2DCC) totally abrogates its sulfatase activity (Morimoto-Tomita et al., 2002) and results in a dominant-negative form (Nawroth et al., 2007) . Transfection of S2DCC into the five Sulf-2 þ lines decreased cell growth but had no effect on H1975 cells (Supplementary Figure 4 ).
Transduction of cells with either of the two Sulf-2-specific shRNAs inhibited cell proliferation, assayed by measuring bromo-deoxyuridine (BrdU) incorporation, by 44-50% in all five Sulf2 þ lines, as compared with the controls (Figure 3d ). Sulf-2 knockdown increased apoptosis (annexin-V staining) by twoto three-fold in the Sulf-2 þ lines ( Figure 3e ). In both cases, there were no effects on H1975 cells. These results indicate that Sulf-2 promotes cell growth in lung cancer cell lines by increasing both proliferation and cell survival.
Sulf-2 knockdown also induced a 40-60% increase in cell-substratum adhesion to fibronectin or collagen ( Supplementary Figure 5a) , and a 15-45% decrease in serum-induced cell migration ( Supplementary  Figure 5b ). Correlated with this increased adhesion, the mobility of PLV-1413-transduced cells (H292 and P-ST), measured after 'wounding' cell monolayers, was reduced by 37-50% ( Figure 3f ). There was no difference in wound closure between PLV-1413-transduced and control H1975 cells (not shown).
Anchorage-independent cell growth is one of the hallmarks of transformed cells and is exhibited by the NSCLC lines and the smoke-transformed lines studied above. We, therefore, investigated the effect of Sulf-2 knockdown on the ability of the cells to grow in soft agar. Sulf-2 knockdown in the Sulf2 þ lines reduced the number of colonies formed in soft agar by 70-82% ( Figure 3g ) as compared with the controls. In contrast, transduction of PLV-1413 had no effect on colony formation by H1975 cells.
Sulf-2 overexpression in non-malignant bronchial epithelial cells induces a transformed phenotype in culture
These loss-of-function findings suggested that Sulf-2 may have transforming capability in lung epithelial cells. To examine the functional consequences of Sulf-2 expression in lung cells, we overexpressed either active or inactive Sulf-2 (S2DCC) in two non-malignant human bronchial epithelial cell lines (BEAS2B and 16HBE14oÀ), both of which are negative for the Sulfs. Transduction resulted in Sulf-2 expression levels comparable to those found in high-expressing lung cancer cell lines (Figure 4a ).
Sulf-2 expression in both BEAS2B and 16HBE14oÀ cell lines resulted in decreased staining by RB4CD12, indicating that the enzyme had the expected activity on cell-surface HSPGs (Figure 4b ). However, S2DCC expression in these cells had no effect on this epitope, confirming the inactivity of this Sulf-2 mutant. Cells expressing S2DCC retained the flattened shape of the parental cells, whereas cells with active Sulf-2 (Supplementary Figure 6a ) were more rounded. In keeping with these morphological changes, cells with active Sulf-2 exhibited decreased cell-substrate adhesion by 40-60% ( Supplementary Figure 6b ). Furthermore, in both wound-repair ( Figure 4c ) and chemotaxis assays ( Supplementary Figure 6c ), migration of active Sulf-2expressing cells was markedly enhanced relative to that of cells with S2DCC or parental cells. With respect to cell growth, active Sulf-2, but not S2DCC, induced a modest (25-28%), but statistically significant, increase (Figure 4d ). As for anchorage-independent growth, BEAS2B and 16HBE14oÀ cells, expressing Sulf-2, formed colonies in soft agar after 18 days, whereas neither parental cells nor S2DCC-transduced cells formed any colonies (Figure 4e ). We established nine clones of Sulf-2-expressing BEAS2B cells from colonies in soft agar, all of which showed increased cell Sulf-2 knockdown reduces the growth of tumors arising from lung cancer cells To examine the contribution of Sulf-2 to the tumorigenicity of the NSCLC cell lines, we injected controltransduced or Sulf-2-knockdown cells subcutaneously Sulf-2 promotes lung carcinogenesis H Lemjabbar-Alaoui et al into nude mice and monitored tumor growth. Tumors derived from H460, H292, Calu-6, P-ST and B-ST cells with knockdown grew at markedly slower rates than those from the control cells (60-85% reduction) ( Figure 5 ). Furthermore, the harvested tumors were greatly reduced in weight ( Supplementary Figure 7) , consistent with an observed decrease in cell proliferation and increase in apoptosis within the tumors (Supplementary Figures 8a and b) . Transduction of H1975 cells with SULF2 shRNA had no effect on tumorigenicity ( Figure 5) .
To examine the effect of Sulf-2 overexpression on non-malignant bronchial epithelial cells, we injected BEAS2B or 16HBE14oÀ cells transduced with Sulf-2 Sulf-2 promotes lung carcinogenesis H Lemjabbar-Alaoui et al into nude mice. Even after 2 months, no tumors formed from either cell type with or without Sulf-2 (not shown). Thus, although Sulf-2 overexpression in bronchial epithelial cells induced many features of malignant transformation in culture, introduction of Sulf-2 alone did not result in full transformation to a tumorigenic state.
Sulf-2 knockdown or expression of catalytically inactive
Sulf-2 inhibits autocrine Wnt signaling in lung cancer cells Previous work has implicated the Sulfs as positive regulators of Wnt signaling in development (Dhoot et al., 2001; Freeman et al., 2008) and in pancreatic cancer cell lines (Nawroth et al., 2007) . These enhancing effects were demonstrated for canonical Wnt signaling, which involves translocation of b-catenin to the nucleus and its participation in a transcriptional complex (Logan and Nusse, 2004; Clevers, 2006 Figure 9a) . To check whether the signaling was autocrine in nature (that is, triggered by extracellular Wnts), we used sFRP and WIF-1, which are soluble extracellular inhibitors of Wnt signaling (Kawano and Kypta, 2003) . When the five cell lines were transfected with sFRP or WIF cDNA, TOP/FOP flash activity was inhibited by 50-60% ( Supplementary Figure 9b ). Consistent with these results, addition of either sFRP1 or WIF protein to the culture medium of the cells reduced TOP/FOP flash activity to a comparable extent (Figure 6a ). Furthermore, the inhibitors markedly reduced cell growth by 30-50% (Figure 6b ). We next asked whether Wnt signaling was regulated by Sulf-2. Knockdown of Sulf-2 in the five cell lines resulted in 45-50% inhibition of TOP/FOP flash activity (Figure 6c ). In addition, Sulf-2knockdown cells showed favored plasma membrane localization for b-catenin, whereas nuclear localization was favored in the control cells (Figure 6d and Supplementary Figure 9c) . Also, Sulf-2 knockdown (H292 cells) led to three-to fourfold reduction in the expression of several Wnt target genes (Cyclin D1, Cyclin D2, Cyclin D3, JUN and MYC), which are involved in cell growth (http://www.stanford.edu/Brnusse/ wntwindow.html; Supplementary Table 3 ). Importantly, addition of sFRP1 or WIF-1 to the culture medium of knockdown cells produced no further inhibition of Wnt signaling ( Supplementary Figure 9d ) or cell growth (Figure 6e) , consistent with the model in which Sulf-2 directly regulates the mobilization of Wnt ligands from HSPG sequestration (Ai et al., 2003) . It is conceivable that Sulf-2 knockdown could also have less direct effects on Wnt signaling as there was an E2-fold reduction in the expression of two WNT genes among the six WNTs expressed in H292 cells ( Supplementary  Table 3 ).
Complementing the knockdown approach, we found that overexpression of dominant-negative S2DCC in the five cell lines inhibited Wnt activity by 40-60%, while (Figure 6f ). In contrast, forced expression of Sulf-2 in cells that lacked it (BEAS2B and 16HBE14oÀ) increased TOP/FOP flash activity four-to five-fold from the baseline value of 1 (Figure 6g ). Sulf-2 promotes lung carcinogenesis H Lemjabbar-Alaoui et al
Discussion
The early view in the literature was that both Sulfs were tumor suppressors (Lai et al., 2003 (Lai et al., , 2004 Dai et al., 2005; Li et al., 2005) . This belief originated from experiments in which forced expression of a Sulf in several tumor lines caused reduced growth-factor signaling by HB-EGF, FGF-2 or HGF, and diminished tumorigenicity. The negative effects of Sulfs on FGF-2 signaling are consistent with the requirement for 6S on HSPGs in the FGF-2 signaling complex (Gallagher, 2001) . The ability of Sulf-1 to inhibit certain growthfactor responses may explain why SULF1 expression is reduced in subsets of tumors (ovarian, hepatocellular) (Lai et al., 2003 (Lai et al., , 2004 and in certain developmental contexts (Wang et al., 2004; Langsdorf et al., 2007; Freeman et al., 2008) . However, consistent with a potential oncogenic role, one or both SULF genes are overexpressed in subsets of multiple tumors (breast, pancreatic, hepatocellular carcinoma, head and neck, and lung) (Lai et al., 2004 (Lai et al., , 2008 Morimoto-Tomita et al., 2005; Grigoriadis et al., 2006; Kudo et al., 2006; Nawroth et al., 2007; Castro et al., 2008) . A strong case for a positive contribution has emerged for Sulf-2 in particular. Not only is SULF2 overexpressed in hepatocellular carcinoma, but high expression is associated with worse prognosis (Lai et al., 2008) . Unbiased screening studies have identified SULF2/sulf2 as a candidate cancer-causing gene in human breast cancer and mouse brain cancer (Johansson et al., 2004; Sjoblom et al., 2006) . Finally, knockdown of Sulf-2 in pancreatic adenocarcinoma cell lines (Nawroth et al., 2007) and hepatocellular cell lines (Lai et al., 2008) reverts their transformed phenotypes in culture and impedes their tumorigenicity in nude mice. The present study is the first to investigate Sulf-2 in NSCLC. The expression of Sulf-2 in NSCLC tumors, taken together with the loss-of-function experiments using NSCLC cell lines and gain-of-function experiments using nonmalignant bronchial epithelial cells, constitutes the strongest evidence, to date, for a positive contribution in malignancy. Notably, two of the NSCLC lines studied represent novel models of tobacco-smokeinduced carcinogenesis, which is responsible for 85% of lung cancers (Sato et al., 2007) . Our findings provide impetus for further investigation of Sulf-2 in NSCLC and other cancers in which it is overexpressed. By monitoring the RB4CD12 epitope we confirmed that the transforming activity of Sulf-2 depends on its activity as an HSPG endosulfatase. Previous studies have shown that HSPGs facilitate the progression of tumors by promoting their growth through direct effects on tumor cells (Alexander et al., 2000; Capurro et al., 2005; Aikawa et al., 2008) or indirect effects on the tumor microenvironment (Fuster and Esko, 2005; Aikawa et al., 2008) . The upregulated Sulf-2 expression in the stroma of NSCLC tumors (in particular adenocarcinomas) may be involved in carcinogenesis mechanisms of the latter type, for example, in promoting angiogenesis or metastasis (Fuster and Esko, 2005; Aikawa et al., 2008) . The extensive literature on heparanase further highlights the importance of HSPGs in cancer (Parish et al., 2001; Vlodavsky et al., 2007) . This endoglycosidase cleaves the HS chains at a few sites and produces large fragments that retain growth-factorbinding activity. Heparanase is upregulated in many tumors and promotes tumor growth and metastasis (Vlodavsky et al., 2007) . Like heparanase, the Sulfs provide a postsynthetic mechanism to edit HSPGs, but do so without cleaving its chains.
The Sulfs positively modulate several signaling pathways including Wnt, BMP, Hedgehog and GDNF (Dhoot et al., 2001; Ai et al., 2003 Ai et al., , 2007 Viviano et al., 2004; Danesin et al., 2006; Nawroth et al., 2007) . Of these, promotion of canonical Wnt signaling is the best validated (Dhoot et al., 2001; Nawroth et al., 2007; Freeman et al., 2008; Tang and Rosen, 2009) . Aberrant activation of Wnt signaling is an important mechanism underlying the pathogenesis of many tumors (Miller et al., 1999; Logan and Nusse, 2004; Clevers, 2006; Klaus and Birchmeier, 2008) . In some cases (for example, colorectal cancers), the pathway is activated by mutations in intracellular signaling intermediates such as APC, axin or b-catenin (Clevers, 2006) . Wnt signaling can also be activated by altered receptorligand interactions at the level of the cell surface, involving changes in the expression of Wnts, soluble extracellular Wnt antagonists or Wnt receptors/coreceptors (Huguet et al., 1994; Hoang et al., 2004; Janssens et al., 2004; Suzuki et al., 2004) . Tumors and cell lines driven by this type of mechanism ('autocrine Wnt signaling') are subject to inhibition by extracellular administration of Wnt antagonists (Bafico et al., 2004; Derksen et al., 2004; You et al., 2004; Mikami et al., 2005; DeAlmeida et al., 2007; Kim et al., 2007; Schlange et al., 2007; Groen et al., 2008) .
In NSCLC, there is emerging evidence for aberrant Wnt signaling, which is based on altered receptor-ligand interactions or membrane-proximal events rather than mutations in downstream components (Furuuchi et al., 2000; Sunaga et al., 2001; Ohgaki et al., 2004; Winn et al., 2006) . Thus, promoters of autocrine Wnt signaling (Wnt1, Wnt2, disheveled) are upregulated (Uematsu et al., 2003; You et al., 2004; Huang et al., 2008; Nakashima et al., 2008) and, conversely, WIF-1 is downregulated in NSCLC tumors . Studies with NSCLC cell lines corroborate the importance of these dysregulated Wnt elements in promoting cell growth (Kim et al., 2007) . Strikingly, all five Sulf-2 þ NSCLC lines studied exhibited autocrine Wnt signaling, which is compatible with the involvement of Sulf-2 in regulating the bioavailability of extracellular Wnt ligands through its endosulfatase action on HSPGs. Consistent with this role for Sulf-2, knockdown of Sulf-2 or introduction of a dominant-negative form of Sulf-2 in these lines caused pronounced inhibition of canonical Wnt signaling, whereas, conversely, forced expression of Sulf-2 in normal bronchial epithelial lines induced Wnt signaling. Furthermore, inhibition of autocrine Wnt signaling or knockdown of Sulf-2 in the NSCLC lines produced equivalent effects on cell growth, which were not augmented by combining both treatments. These findings not only corroborate the importance of autocrine Wnt signaling in the growth of NSCLC lines (Kim et al., 2007) , but also establish that Sulf-2 is required for this autocrine pathway.
Lung cancer is a heterogeneous disease involving dysregulation of a number of signaling pathways, most frequently involving EGFR and KRAS (Osada and Takahashi, 2002; Sato et al., 2007) . The relationship of Sulf-2 to these pathways remains to be determined. Intriguingly, Hynes and co-workers have demonstrated that autocrine Wnt signaling can transactivate epidermal growth factor receptor (EGFR) in breast cancer cell lines (Schlange et al., 2007) . Although further validation is required, the results presented above raise the possibility that Sulf-2 could be a therapeutic target in NSCLC. Sulf-2 is an extracellular enzyme and thus is potentially amenable to inhibition by either antibody-based or small-molecule drugs. Since Sulf-2 is secreted and may enter body fluids, it also merits consideration as a potential biomarker of lung cancer.
Materials and methods

Constructs
Descriptions are provided under Supplementary Information.
Reverse transcription-PCR and data mining
For analysing SULF expression in published gene microarray studies, we used the oncomine database (www.oncomine.org) and the Consortium for Functional Glycomics data of Dr Rittenhouse-Olson (http://www.functionalglycomics.org/ glycomics/publicdata/microarray.jsp; no. 887). For analysing SULF expression by PCR and reverse transcription-PCR, the methodology is provided under Supplementary Information.
Sulf-2 antibodies
The peptide-based polyclonal antibody against HSulf-2 was produced as described (Morimoto-Tomita et al., 2005) . Monoclonal antibodies were produced by ProSci Inc. (Poway, CA, USA). A sulf2-null mouse (Lum et al., 2006) (provided by Drs Joanna Phillips and Zena Werb) was immunized with recombinant HSulf-2 protein (15 mg over three injections); 2B4, one of the resulting monoclonal antibodies, was used. Its characterization is presented in Supplementary Figure 3 .
Immunohistochemistry
Under UCSF CHR approval (H1060-27616-01), archived paraffin-embedded tissue blocks were obtained for 10 cases each of squamous lung carcinoma and adenocarcinoma. Sections measuring 4 mm were subjected to heat-induced epitope retrieval with Trilogy (Cell Marque, Rocklin, CA, USA) and stained with 2 mg/ml of 2B4 for 2 h. A monoclonal antibody directed to herpes simplex virus-I/II served as control. Antibody binding was visualized by the Dako Envision ( þ ) system (Dako, Carpinteria, CA, USA, cat. no. K4011).
Immunoblotting assays
The methodology for immunoblotting is provided under Supplementary Information.
Cell lines and cell culture H460, H292, A549, Calu-6, Calu-3 and BEAS2B cells were from American Type Culture Collection. B-ST and P-ST are described under section Results. 16HBE14oÀ cells were from Dr Keith Mostov (UCSF). All cells were grown in RPMI-1640 with 10% fetal bovine serum and penicillin/streptomycin. Human embryonic kidney-293 cells were maintained in Dulbecco's Modified Eagle's Medium with 10% fetal bovine serum and penicillin/streptomycin.
HSPG sulfation analysis
To determine the effects of Sulf-2 knockdown on HSPGs, we used a phage-display antibody (RB4CD12) (Dennissen et al., 2002) with an irrelevant antibody as control. A Cy3conjugated mouse anti-vesicular somatitis virus secondary antibody (Sigma, St Louis, MD, USA) was used and cells were analysed by flow cytometry.
Cell growth, proliferation and survival assays
The methodology for cell growth, proliferation and survival assays is provided under Supplementary Information.
In vitro cell migration and cell adhesion assays
The methodology for in vitro cell migration and cell adhesion assays is provided under Supplementary Information.
Monolayer wound-healing assays Cells were grown to confluence on six-well plates. Scratches were made with a pipette tip. Cell migration was quantified by measuring the width of the wounds at 0, 24, 48 and 72 h.
Colony formation on soft agar
Colonies were formed on soft agar by following the methodology provided under Supplementary Information.
Wnt luciferase reporter assays Wnt luciferase reporter assays followed the methodology provided under Supplementary Information.
Tumorigenicity assays and histological evaluation of xenografts A total of 5 Â 10 6 cells, transduced with either control or Sulf-2 shRNA, were injected into the flanks of 5-week-old athymic, male, BALB/c nu/nu mice (five mice per group). Tumor growth was monitored every 2-3 days. Groups of mice were killed when the largest tumor nodules attained a diameter of 0.8 cm (after 25-40 days). Tumors were harvested, weighed and processed for histology. All procedures had UCSF IACUC approval. Some of the mice were injected intraperitoneally with BrdU 2 h prior to being killed. Tissue sections were immunostained with a BrdU antibody (BD Biosciences, San Jose, CA, USA) or with the active caspase-3 antibody. Tissue sections were incubated with the corresponding peroxidase-conjugated secondary antibody, with visualization with Nova Red and counterstaining with hematoxylin. The numbers of BrdU þ or active caspase-3 þ cells were counted in four high-power fields for each tissue section, with three sections per tumor.
Statistical analysis
All numerical data were calculated as means ± s.d.s or ± s.e.m.s. Differences between groups were compared with Student's t-test. Paired tumor/control samples were compared by paired two-tailed t-test. P-value p0.05 was considered significant.
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